Found 343 bookmarks
Newest
Chemical Linkers in Antibody-Drug Conjugates (ADCs) (RSC Publishing)
Chemical Linkers in Antibody-Drug Conjugates (ADCs) (RSC Publishing)
The covalent conjugation of potent cytotoxic agents to monoclonal antibodies, known as antibody-drug conjugates (ADCs) is a powerful approach in the field of targeted treatment of cancer. Clearly, both monoclonal antibody and cytotoxic payload are crucial elements in determining the clinical value of an ADC and have receive ample attention. However, the structural element connecting the two –the chemical linker– also plays an essential role in mode-of-action, efficacy, pharmacokinetics and safety profile of an ADC, but is often underappreciated in considerations of ADC design.Chemical Linkers in Antibody–Drug Conjugates aims to shine a detailed light on the various key attributes of chemical linkers in ADCs, for drug-to-antibody ratio, for stability, for release mechanism of payload, for pharmacokinetics, for stability determination, and for efficacy and safety. Ideal for postgraduate students and active researchers in drug discovery and development, this book provides a comprehensive description of linkers used in ADCs (clinical and late preclinical), insight into key quality attributes of linkers for ADCs, and aids the reader in understanding the role of linker chemistry and designing new ADCs.
·pubs.rsc.org·
Chemical Linkers in Antibody-Drug Conjugates (ADCs) (RSC Publishing)
Charting the choppy history of ‘magic bullet’ antibody-drug conjugates
Charting the choppy history of ‘magic bullet’ antibody-drug conjugates
Antibody-drug conjugates allow for targeted delivery of chemotherapy to tumours, therefore reducing off-target effects for patients.
·pharmaceutical-technology.com·
Charting the choppy history of ‘magic bullet’ antibody-drug conjugates
Linker technologies and release mechanisms for antibody–drug conjugates | Optimizing Antibody-Drug Conjugates for Targeted Delivery of Therapeutics
Linker technologies and release mechanisms for antibody–drug conjugates | Optimizing Antibody-Drug Conjugates for Targeted Delivery of Therapeutics
·futuremedicine.com·
Linker technologies and release mechanisms for antibody–drug conjugates | Optimizing Antibody-Drug Conjugates for Targeted Delivery of Therapeutics
Antibody-Drug Conjugate (ADC) Technology - Creative Biolabs
Antibody-Drug Conjugate (ADC) Technology - Creative Biolabs
Creative Biolabs has developed antibody-drug conjugate (ADC) technology to generate precision medicines targeting specific surface antigens to fight diseases.
·creative-biolabs.com·
Antibody-Drug Conjugate (ADC) Technology - Creative Biolabs
Vincerx—next-generation antibody–drug conjugates with enhanced therapeutic windows
Vincerx—next-generation antibody–drug conjugates with enhanced therapeutic windows
Vincerx applies a modular approach in the development of antibody–drug conjugates by incorporating novel targeting and safety features. The company’s lead compounds exhibit high efficacies with minimal toxicities that are expected to improve therapeutic windows. Vincerx believes that partners with first-in-class antibodies, clinical stage antibodies or ADCs against promising targets will benefit from Vincerx’s next-generation payload-linker technologies.
·nature.com·
Vincerx—next-generation antibody–drug conjugates with enhanced therapeutic windows
Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030
Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030
Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030 Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030 - Market research report and industry analysis - 13084685
·marketresearch.com·
Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030
Antibody–drug conjugates: Recent advances in linker chemistry - ScienceDirect
Antibody–drug conjugates: Recent advances in linker chemistry - ScienceDirect
Antibody–drug conjugates (ADCs) are gradually revolutionizing clinical cancer therapy. The antibody–drug conjugate linker molecule determines both the…
·sciencedirect.com·
Antibody–drug conjugates: Recent advances in linker chemistry - ScienceDirect
Antibody Drug Conjugates (ADCs)-Linker and Conjugation Technologies Market, 2019-2030
Antibody Drug Conjugates (ADCs)-Linker and Conjugation Technologies Market, 2019-2030
/PRNewswire/ -- INTRODUCTION With six approved drugs, namely POLIVY™ (2019), LUMOXITI™ (2018), BESPONSA® (2017), MYLOTARG™ (2017, reapproval), KADCYLA® (2013)...
·prnewswire.com·
Antibody Drug Conjugates (ADCs)-Linker and Conjugation Technologies Market, 2019-2030
Linker and Conjugation Technology; and Improvements - Antibody‐Drug Conjugates - Wiley Online Library
Linker and Conjugation Technology; and Improvements - Antibody‐Drug Conjugates - Wiley Online Library
The crux of successful antibody-drug conjugates (ADCs) rests on an indomitable conjugation and linker system that securely attaches a drug payload to an antibody. Linker and conjugation technologies ...
·onlinelibrary.wiley.com·
Linker and Conjugation Technology; and Improvements - Antibody‐Drug Conjugates - Wiley Online Library
Industry Taking Notice of Araris Biotech's Linker Technology for ADC Delivery | BioSpace
Industry Taking Notice of Araris Biotech's Linker Technology for ADC Delivery | BioSpace
The company’s technology is designed to attach any off-the-shelf antibody with any payload without the need for modification.
·biospace.com·
Industry Taking Notice of Araris Biotech's Linker Technology for ADC Delivery | BioSpace
Advances in Linker Technology: Improving the Safety and Efficacy of Antibody Drug Conjugates
Advances in Linker Technology: Improving the Safety and Efficacy of Antibody Drug Conjugates
The targeted delivery of cytotoxic drugs using antibody drug conjugates would not be possible without effective linkers to connect and then release the key chemical and biological materials.
·biopharminternational.com·
Advances in Linker Technology: Improving the Safety and Efficacy of Antibody Drug Conjugates
Linker technologies for antibody-drug conjugates - PubMed
Linker technologies for antibody-drug conjugates - PubMed
Antibody-drug conjugates (ADCs), which combine the specificity, favorable pharmacokinetics, and biodistribution of a monoclonal antibody (mAb) with the cytotoxic potency of a drug, are promising new therapies for cancer. Along with the development of monoclonal antibodies (mAbs) and cytotoxic drugs, …
·pubmed.ncbi.nlm.nih.gov·
Linker technologies for antibody-drug conjugates - PubMed
Parallel lines in the left breast - implantable device | Radiology Case | Radiopaedia.org
Parallel lines in the left breast - implantable device | Radiology Case | Radiopaedia.org
The lines represent reverberation artifacts of a small wireless insertable cardiac monitor (ICM), also known as an implantable loop recorder (ILR). This particular device is a Medtronic Reveal LINQ insertable cardiac monitoring system. The devi...
·radiopaedia.org·
Parallel lines in the left breast - implantable device | Radiology Case | Radiopaedia.org
Shaft Sinking Equipment Market In-Depth Analysis including key players Komatsu, Sandvik Mining and Construction, CRTG, Herrenknecht AG, Kawasaki, Robodrill, Ishikawajima-Harima, NHI, etc. – Murphy's Hockey Law
Shaft Sinking Equipment Market In-Depth Analysis including key players Komatsu, Sandvik Mining and Construction, CRTG, Herrenknecht AG, Kawasaki, Robodrill, Ishikawajima-Harima, NHI, etc. – Murphy's Hockey Law
·murphyshockeylaw.net·
Shaft Sinking Equipment Market In-Depth Analysis including key players Komatsu, Sandvik Mining and Construction, CRTG, Herrenknecht AG, Kawasaki, Robodrill, Ishikawajima-Harima, NHI, etc. – Murphy's Hockey Law
notamazgaming.com/?h=f31743121e&tl=veration-cellyric.com&imp=1&cep=EslgKW0e4JVO6xfL2F-x96VvASFHON-ceAtU53h0vKVRIGmex4O8rpddTXnjriT8jmb8TvVq_XodLPCceHpLlPegjJ3UGyHG7RdT6-sPBAYefkk7LdCz1D8WF5UfBm3UAykgWFl1XCNF1mq0_m0J4vSKTFZzLYVmvCFZ8n-ejJTYGR6kucswcqVMihRzNYWLrzBaX-7PnbG4HO1oPQhCS4nmR9Ypjm07xjHQDYa864B49FvZcJFw6GoSmE1fXzuUFu3zRuQuzm62xdLXueK07JFIaow6kruMFv5sZc2TorJbl3mU9bBsYCREc27q9OZ0r3UKnwFGW0qSwdWMW5Nn-KQTUpgqHWFqGlNwXPUVVPFbYro4JJNGKG_8z3N2dwpPj0_zE9iwPJGDqrNqIU82iFIVLJS9VuLkaGPQ2mnfIK05AkNnsKt8ZdLdLLzsnuEt7PR-EwXie0fYz5bpcNGTxyk2Yt1mte0qsM48uabBsrk&lptoken=169230ce681147260946&placement=14269848&campaign=481191&Landing_ID=2951399&ntk=63&subid_short=39de58e1d4d1af3677b60a750b73ef83
notamazgaming.com/?h=f31743121e&tl=veration-cellyric.com&imp=1&cep=EslgKW0e4JVO6xfL2F-x96VvASFHON-ceAtU53h0vKVRIGmex4O8rpddTXnjriT8jmb8TvVq_XodLPCceHpLlPegjJ3UGyHG7RdT6-sPBAYefkk7LdCz1D8WF5UfBm3UAykgWFl1XCNF1mq0_m0J4vSKTFZzLYVmvCFZ8n-ejJTYGR6kucswcqVMihRzNYWLrzBaX-7PnbG4HO1oPQhCS4nmR9Ypjm07xjHQDYa864B49FvZcJFw6GoSmE1fXzuUFu3zRuQuzm62xdLXueK07JFIaow6kruMFv5sZc2TorJbl3mU9bBsYCREc27q9OZ0r3UKnwFGW0qSwdWMW5Nn-KQTUpgqHWFqGlNwXPUVVPFbYro4JJNGKG_8z3N2dwpPj0_zE9iwPJGDqrNqIU82iFIVLJS9VuLkaGPQ2mnfIK05AkNnsKt8ZdLdLLzsnuEt7PR-EwXie0fYz5bpcNGTxyk2Yt1mte0qsM48uabBsrk&lptoken=169230ce681147260946&placement=14269848&campaign=481191&Landing_ID=2951399&ntk=63&subid_short=39de58e1d4d1af3677b60a750b73ef83
·notamazgaming.com·
notamazgaming.com/?h=f31743121e&tl=veration-cellyric.com&imp=1&cep=EslgKW0e4JVO6xfL2F-x96VvASFHON-ceAtU53h0vKVRIGmex4O8rpddTXnjriT8jmb8TvVq_XodLPCceHpLlPegjJ3UGyHG7RdT6-sPBAYefkk7LdCz1D8WF5UfBm3UAykgWFl1XCNF1mq0_m0J4vSKTFZzLYVmvCFZ8n-ejJTYGR6kucswcqVMihRzNYWLrzBaX-7PnbG4HO1oPQhCS4nmR9Ypjm07xjHQDYa864B49FvZcJFw6GoSmE1fXzuUFu3zRuQuzm62xdLXueK07JFIaow6kruMFv5sZc2TorJbl3mU9bBsYCREc27q9OZ0r3UKnwFGW0qSwdWMW5Nn-KQTUpgqHWFqGlNwXPUVVPFbYro4JJNGKG_8z3N2dwpPj0_zE9iwPJGDqrNqIU82iFIVLJS9VuLkaGPQ2mnfIK05AkNnsKt8ZdLdLLzsnuEt7PR-EwXie0fYz5bpcNGTxyk2Yt1mte0qsM48uabBsrk&lptoken=169230ce681147260946&placement=14269848&campaign=481191&Landing_ID=2951399&ntk=63&subid_short=39de58e1d4d1af3677b60a750b73ef83